In her first public appearance since her unceremonious ouster as executive editor of The New York Times last Wednesday, Abramson was masterful Monday as she gave the commencement address at Wake Forest University.
Over the weekend, Times publisher Arthur Sulzberger Jr., very much on the defensive for the way he pushed Abramson out the door, was harshly critical of the woman he chose less than three years ago to run the newsroom of the nation's preeminent news outlet.
"I concluded that her management of the newsroom was simply not working out," he said in a statement. "During her tenure, I heard repeatedly from her newsroom colleagues, women and men, about a series of issues, including arbitrary decision-making, a failure to consult and bring colleagues with her, inadequate communication and the public mistreatment of colleagues."
5 Best Building Product Stocks To Watch Right Now: John Hancock Premium Dividend Fund (PDT)
John Hancock Patriot Premium Dividend Fund II (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide high current income together with capital growth. The Fund invests in a diversified portfolio of dividend-paying preferred and common stocks. It invests at least 80% of its net assets in dividend-paying securities. The Fund will normally invest more than 65% of its total assets in securities of companies in the utilities industry. Preferred stocks and debt obligations in which the Fund invests are rated investment grade (at least BBB by Standard & Poor�� or Baa by Moody�� Investors Service) at the time of investment, or will be preferred stocks of issuers of investment-grade senior debt, or if not rated, will be of comparable quality as determined by the Fund�� investment advisor. The Fund will invest in common stocks of issuers, whose senior debt is rated investment grade, or in the case of issuers that have no rated senior debt outstanding, whose senior debt is considered by its advisor to be of comparable quality. Its portfolio includes common stocks, preferred securities and short-term investments.
In May 2007, the Fund completed the acquisition of John Hancock Patriot Preferred Dividend Fund. In June 2007, the Fund acquired Hancock John Patriot Global Dividend Fund and John Hancock Patriot Premium Div Fund I. On October 10, 2007, the Fund completed the acquisition of John Hancock Patriot Select Dividend Trust Fund.
The Fund invests in industries, such as multi-utilities, electric utilities, investment banking and brokerage, other diversified financial services, oil and gas exploration and production, gas utilities, consumer finance, life and health insurance, and integrated telecommunication services. John Hancock Patriot Premium Dividend Fund II�� investment advisor is John Hancock Advisers, LLC, a wholly owned subsidiary of John Hancock Financial Services, Inc., which is a subsidiary of Manulife Fina! ncial Corporation. The Fund�� sub-advisor is MFC Global Investment Management (U.S.), LLC.
Advisors' Opinion:- [By Ari Charney]
John Hancock Premium Dividend Fund (PDT) tends to allocate roughly 30% to 40% of the portfolio to equities and 60% to 70% to preferred stock, with the utilities and financial sectors as its main focus.
Best Defensive Companies To Own In Right Now: Avalon Rare Metals Inc (AVL)
Avalon Rare Metals Inc. (Avalon) is a Canada-based mineral exploration and development company. The Company�� primary focus is on rare metals and minerals, including tin, lithium, tantalum, niobium, cesium, indium, gallium, zirconium and calcium feldspar. It is in the process of exploring or developing three of its six mineral resource properties. The Company�� active projects (Thor Lake Rare Metals Project (Thor Lake), Separation Rapids and East Kemptville) are rare minerals or rare metals properties that are at an advanced stage with identified mineral resources. Thor Lake is the Company�� leading project. The Thor Lake is located in the Mackenzie Mining District of the Northwest Territories, approximately five kilometers north of the Hearne Channel of Great Slave Lake and approximately 100 kilometers southeast of the city of Yellowknife. It comprises five contiguous mining leases totalling 10,449 acres (4,249 hectares) and three claims totalling 4,597 acres (1,869 hectares). Advisors' Opinion:- [By James E. Brumley]
Rare Element Resources Ltd (NYSEMKT:REE) has been getting more than its fair share of attention of late.... bullish attention, to be precise. The stock's benefited from the attention too, with REE shares up 58% in the past two and a half weeks. As compelling as that move is, however, it's not the best rare earth bet at this point. If you like Rare Element Resources, you'll love Avalon Rare Metals Inc. (NYSEMKT:AVL). Unlike REE, AVL isn't already overbought. Indeed, it's just getting started.
First and foremost, it's worth noting that the undertow pushing Avalon Rare Metals and Rare Element Resources Ltd shares upward is doing the same for most rare earth metal miners. That undertow is simply a broad price improvement for rare earth elements. Since July's low, neodymium ("the biggie) prices have advanced from $75/kg to the current price of $103/kg, and are still going strong. Some observers have already suggested the proverbial bottom has been made, and their arguments actually hold up pretty well. That's why REE and AVL have been such - no pun intended - hot commodities of late... this rebound in rare element prices seems to be the real deal.
So what's wrong with Rare Element Resources Ltd that isn't wrong with Avalon Rare Metals? In simplest terms, AVL isn't overbought right now, while REE is.
With just a quick glance at the chart of Rare Element Resources Ltd we can see that shares had already been hot, gapping higher back on the 16th, yet never looking back. Now it's up huge, and on huge volume. In fact, today's big 11% pop will be the highest volume day we've seen in months.
On the surface it seems bullish, but this is one of those "too much of anything is still too much" situations. REE may be hot, but it's well overextended already, and today's extreme bullishness may be actually be a blowoff top.
AVL, on the flipside, isn't nearly as overextended right now. In fact, it appears to just be getting started. Though it to - [By Doug Ehrman]
The broader comments are a boon for the industry, explaining why competitors like Avalon Rare Metals (NYSEMKT: AVL ) traded up nearly 10% and Rare Earth Elements (NYSEMKT: REE ) surged over 12% on the news. If industrial demand for rare-earth elements is stabilizing and beginning to build, then all three of these companies will benefit. High inventories in the hands of customers have been a major drag on prices for an extended period, and If this trend is reversing, Molycorp should see continuing strength in the later part of the year.
- [By James E. Brumley]
Back on September 24th I pointed out how Avalon Rare Metals Inc. (NYSEMKT:AVL) was a superior stock pick to Rare Element Resources Ltd (NYSEMKT:REE), even if only for short-term technical reasons. Either way, however, the rebound in the prices of most rare earth metals was going to be good for both REE and AVL. The one name conspicuously missing from the bunch, of course, was Molycorp Inc. (NYSE:MCP). Well, you can finally add MCP to the buy list as well. In fact, the different path it took to technical soundness may well make Molycorp the best pick of the bunch right now.
- [By Roberto Pedone]
One under-$10 rare earth metals player that's trending very close to triggering a major breakout trade is Avalon Rare Metals (AVL), which is a Canadian mineral exploration and development stage company with its focus on the rare metals and minerals. This stock has been hit hard by the bears so far in 2013, with shares off by 40%.
If you take a look at the chart for Avalon Rare Metals, you'll notice that this stock recently pulled back after a monster run to the upside, with shares selling off from its high of 90 cents to its low of 71 cents per share. Shares of AVL are now starting to bounce off that low and trend back above its 50-day moving average at 74 cents per share. That move is quickly pushing this stock within range of triggering a major breakout trade above a key descending trendline and above some near-term overhead resistance levels.
Traders should now look for long-biased trades in AVL if it manages to break out above some near-term overhead resistance levels at 82 to 90 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 447,084 shares. If that breakout triggers soon, then AVL will set up to re-test or possibly take out its next major overhead resistance levels at $1.14 to $1.22 a share. Any high-volume move above those levels will then put its next major overhead resistance levels at 41.34 to $1.64 within range for shares of AVL.
Traders can look to buy AVL off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 71 cents to 65 cents per share. One can also buy AVL off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Defensive Companies To Own In Right Now: Mesabi Trust (MSB)
Mesabi Trust operates as a royalty trust in the United States. The company produces iron ore pellets. It holds interest in the Peter Mitchell mine located in the Mesabi Iron Range near Babbitt, Minnesota. The company holds various agreements with the Northshore Mining Company that mines iron ore, which is in the form of taconite, crushes it, separates the iron particles from the non-metallic, and forms the resulting concentrate into pellets that are shipped for use in steel-producing blast furnaces of customers of CCI, a mining company that produces iron pellets in North America. Mesabi Trust was founded in 1919 and is based in New York, New York.
Advisors' Opinion:- [By Selena Maranjian]
Patience, Grasshopper
For starters, imagine that you invested in Mesabi Trust (NYSE: MSB ) about a year ago and you're down some 20% on your investment. Your holding might be looking to you like an answer to the question, "What is investment panic, Alex?" But don't be so hasty. Ask yourself why you bought it. Mesabi Trust is a royalty trust that receives and then pays out to shareholders a portion of the proceeds from iron mined by a�Cliffs Natural Resources�subsidiary. Some might avoid it because royalty trusts often have expiration dates, but it's worth noting that Mesabi's is rather�far away. But slowdown in demand�for ore is a concern, one that has been�an issue for Cliffs, too.
Best Defensive Companies To Own In Right Now: Sagent Pharmaceuticals Inc.(SGNT)
Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. It offers a range of products across anti-infective, oncolytic, and critical care indications in various presentations, including single-and multi-dose vials, pre-filled ready-to-use syringes, and premix bags. The company?s anti-infective products include Levofloxacin, a fluoroquinolone antibacterial for the treatment of various infections caused by susceptible bacteria in adults of age 18 years or older; and Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structure, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients. Its oncology products comprise Gemcitabine, a nucleoside metabolic inhibitor used for the treatment of ovarian, breast, lung, and panc reatic cancers; and Topotecan, a topoisomerase inhibitor for small cell lung cancer sensitive disease. The company also offers critical care products consisting of Adenosine, an antiarrhythmic used for the treatment of cardiac rhythm disturbances; and Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2011, it marketed 33 generic injectable products; and had a new product pipeline that included 36 products represented by 63 Abbreviated New Drug Applications (ANDAs). The company sells its products to pharmaceutical wholesale companies, which then distribute the products to end-user hospitals, long-term care facilities, alternate care sites, and clinics. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.
Advisors' Opinion:- [By Rich Smith]
Sagent Pharmaceuticals (NASDAQ: SGNT ) �is recalling three lots of Vecuronium Bromide for Injection, 10mg (NDC number 25021-657-10). Vecuronium Bromide for Injection is a neuromuscular blocking agent used in addition to general anesthesia to facilitate insertion of endotracheal tubes, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.�
- [By John Seward]
Among the changes announced Tuesday, Affiliated Managers Group (NYSE AMG) will replace Forest Laboratories Inc. (NYSE: FRX) in the S&P 500 after the close of trading on Monday, June 30. LaSalle Hotel Properties (NYSE: LHO) will replace Affiliated Managers in the S&P MidCap 400 and Sagent Pharmaceuticals Inc. (NASDAQ: SGNT) will replace LaSalle in the S&P SmallCap 600.
- [By CRWE]
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, reported financial results for the quarter ended March 31, 2012.
- [By James Brumley]
In no particular order…
Sagent Pharmaceuticals (SGNT)Though Sagent Pharmaceuticals (SGNT) makes a few dozen generic drugs and has a similar number in the works, odds are good most investors couldn’t name a single one of them… and that’s a good thing for anyone on the hunt for cheap stocks from the pharma world.
Best Defensive Companies To Own In Right Now: MWI Veterinary Supply Inc.(MWIV)
MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.
Advisors' Opinion:- [By Rupert Hargreaves]
Pet-related companies are highly sought after
Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis -- greater demand for animal treatments will lead to more demand for the distribution of animal health products. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on MWI Veterinary Supply (Nasdaq: MWIV ) , whose recent revenue and earnings are plotted below. - [By Ben Levisohn]
Overvalued companies include MWI Veterinary (MWIV) and�Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls�Aratana (PETX) a “hidden gem.”
Best Defensive Companies To Own In Right Now: VASCO Data Security International Inc. (VDSI)
VASCO Data Security International, Inc., through its subsidiaries, engages in the design, development, marketing, and support of hardware and software security systems that manage and secure access to information assets worldwide. The company offers hardware and software products in the areas of user authentication, electronic signatures, and digital signatures/public key infrastructure. It provides VACMAN Controller that supports multiple authentication technologies, including passwords, dynamic password technology, electronic signatures, digital signatures, and certificates and biometrics on one platform. The company also offers IDENTIKEY Server, a centralized authentication server that supports the deployment, use, and administration of DIGIPASS user authentication. In addition, it provides aXs GUARD Identifier, a standalone authentication solution, which offers two-factor authentication for remote access to a corporate network or to Web-based in-house business applicat ions; and aXs GUARD Gatekeeper that integrates DIGIPASS to provide secure two factor user authentication. Further, the company offers DIGIPASS product line exists as a family of software and hardware client authentication products and services for authenticating users to any network, including the Internet. Its DIGIPASS solution calculates dynamic signatures and passwords to authenticate users on a computer network and for various other applications. The DIGIPASS technology is also designed to operate on desktop personal computers or laptops, personal digital assistants, mobile phones, and smart cards. VASCO sells its security solutions through its direct sales force, as well as through distributors, resellers, and systems integrators. The company was founded in 1996 and is headquartered in Oakbrook Terrace, Illinois.
Advisors' Opinion:- [By Seth Jayson]
VASCO Data Security International (Nasdaq: VDSI ) reported earnings on July 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), VASCO Data Security International whiffed on revenues and missed estimates on earnings per share. - [By Sally Jones]
Vasco Data Security (VDSI): ReducedDown 20% over 12 months, Vasco Data Security has a market cap of $316.26 million; its shares were traded at around $8.01 with a P/E ratio of 27.40 and a P/B of 2.00.
No comments:
Post a Comment